HCV POLYMERASE INHIBITORS
The present invention provides compounds of the formulawherein B is a nucleobase selected from the groups (a)-(b)and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects. В изобретении представлены соед...
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English Russian |
| Published |
31.01.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides compounds of the formulawherein B is a nucleobase selected from the groups (a)-(b)and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
В изобретении представлены соединения, характеризующиеся формулойгде B представляет собой нуклеотидное основание, выбранное из групп (a) и (b)а другие переменные указаны в формуле изобретения, которые пригодны при лечении или профилактике вируса гепатита C, а также связанных с этим аспектов. |
|---|---|
| AbstractList | The present invention provides compounds of the formulawherein B is a nucleobase selected from the groups (a)-(b)and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.
В изобретении представлены соединения, характеризующиеся формулойгде B представляет собой нуклеотидное основание, выбранное из групп (a) и (b)а другие переменные указаны в формуле изобретения, которые пригодны при лечении или профилактике вируса гепатита C, а также связанных с этим аспектов. |
| Author | KALAYANOV Genadiy WAEHLING Horst TORSSELL Staffan |
| Author_xml | – fullname: TORSSELL Staffan – fullname: KALAYANOV Genadiy – fullname: WAEHLING Horst |
| BookMark | eNrjYmDJy89L5WSQ9HAOUwjw94n0dQ1yDHZV8PTz8HTyDPEPCuZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfGujgZGFpbmJk6GxoRVAABtMCEB |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | ИНГИБИТОРЫ ПОЛИМЕРАЗЫ HCV |
| ExternalDocumentID | EA028974B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EA028974B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:55:11 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Russian |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EA028974B13 |
| Notes | Application Number: EA20160090452 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180131&DB=EPODOC&CC=EA&NR=028974B1 |
| ParticipantIDs | epo_espacenet_EA028974B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20180131 |
| PublicationDateYYYYMMDD | 2018-01-31 |
| PublicationDate_xml | – month: 01 year: 2018 text: 20180131 day: 31 |
| PublicationDecade | 2010 |
| PublicationYear | 2018 |
| RelatedCompanies | MEDIVIR AB |
| RelatedCompanies_xml | – name: MEDIVIR AB |
| Score | 3.1191037 |
| Snippet | The present invention provides compounds of the formulawherein B is a nucleobase selected from the groups (a)-(b)and the other variables are as defined in the... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| Title | HCV POLYMERASE INHIBITORS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180131&DB=EPODOC&locale=&CC=EA&NR=028974B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUxJNAId-qyblgaMBmCiSNMFVgqmusbJaWamacAGrwn4yHxfPzOPUBOvCNMIJoYM2F4Y8Dmh5eDDEYE5KhmY30vA5XUBYhDLBby2slg_KRMolG_vFmLrogbtHRtagI6PUXNxsnUN8Hfxd1ZzdrZ1dVTzC7IFTaiZmzgB-0msoEY06JR91zAn0J6UAuQKxU2QgS0AaFZeiRADU1GpMAOnM-zeNWEGDl_odDeQCc15xSIMkh7OYQoB_j6RoJs5g10VPP08PJ08Q_yDgkUZ5N1cQ5w9dIF2xMO9E-_qCHOMsRgDC7CTnyrBoGCUnGZqkmpkYm5gkWhimJxkmWRuaJloZpxmnGKUmpaSJMkggcsUKdxS0gxcoEABDRkYG8owsJQUlabKAivRkiQ5sP8BsW5zpA |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1JT8JAFH4haMSbogbc6MH01mjbKYVDY-iWVrsFKsFT022CFyVQ4t_3TdOqF26TmWSWN_PmbTPfA3hIi1RioM8CpbgNeCiogEJBEeScjhWKCi-pIfP9YOy8kZeVsurAuv0LU-OEftfgiMhROfJ7Vd_Xmz8nllm_rdw9Zh9Y9fVsx5rJN9axOGHwMbypa1YUmqHBG4ZmzfhgrrGAmkp0tJOOVIbNyxSnpc7-pGz-CxT7DI4j7OuzOofOdt-HntHmXevDid-Eu7HYcN7uAoaOseSi0HtnmTkXFucGjqu7cThfXMLItmLDEXCM5Hc5iTVrJyNfQReN_HIAnJRThZQSUZ8mKRHzbJqp4jQdy1QupJIW2RAGh3q5Ptw0gp4T-17iucHrDZwyAjH3gSzeQrfa7ss7FKhVdl_T4gdBjXaR |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HCV+POLYMERASE+INHIBITORS&rft.inventor=TORSSELL+Staffan&rft.inventor=KALAYANOV+Genadiy&rft.inventor=WAEHLING+Horst&rft.date=2018-01-31&rft.externalDBID=B1&rft.externalDocID=EA028974B1 |